Atai Beckley N.V. Income Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
License revenue
Operating expenses:
Research and development
Acquisition of in-process research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense), net:
Interest income
Change in fair value of contingent consideration liability - related parties
Change in fair value of securities carried at fair value
Change in fair value of convertible promissory notes
Change in fair value of derivative liability
Change in fair value of warrant liability
Unrealized loss on other investments held at fair value
Loss on conversion of convertible promissory notes
Loss on asset acquisition of a variable interest entity
Gain on consolidation of a variable interest entity
Interest expense
Benefit from research and development tax credit
Change in fair value of assets and liabilities, net
Gain on settlement of pre-existing contract
Impairment of other investments
Gain on deconsolidation of a variable interest entity, net
Gain on dissolution of a variable interest entity
Foreign exchange loss, net
Other income (expense), net
Total other income (expense), net

Net loss before income taxes
Benefit from (provision for) income taxes
Gain on dilution of equity method investment, net of tax
Losses from investments in equity method investees, net of tax
Net loss
Net loss attributable to noncontrolling interests
Net loss attributable to ATAI Life Sciences N.V. stockholders
Net loss per share attributable to ATAI Life Sciences N.V. stockholders — basic and diluted
Weighted average common shares outstanding attributable to ATAI Life Sciences N.V. stockholders — basic and diluted
Net loss per share attributable to ATAI Life Sciences N.V. shareholders basic
Net loss per share attributable to ATAI Life Sciences N.V. shareholders diluted
Weighted average common shares outstanding attributable to ATAI Life Sciences N.V.Stockholders basic
Weighted average common shares outstanding attributable to ATAI Life Sciences N.V. Stockholders diluted

Comments